University of Colorado Cancer Center investigator Paul A. Bunn Jr., a University of Colorado Center Center investigator, is one of 16 people nationwide selected by oncology industry peers for remarkable achievements in research and/or clinical practice, and has been honored with one of the 2014 “Giants of Cancer Care” awards.
The awards, which recognize and celebrate individuals who have achieved landmark success within the field of oncology, were presented in May by OncLive, the official home of Oncology and Biotech News, OncologyLive, Urologists in Cancer Care, Oncology Nursing News, Oncology Business Management and Contemporary Oncology.
Bunn’s research interests focus on novel therapies for lung cancer. He has published more than 300 articles in peer-reviewed journals, over 122 reviews and editorials, and 90 book chapters on lung cancer. His studies have set standards for the treatment of lung cancer, have identified issues of natural history and have identified biomarkers of prognosis and therapy selection. Bunn is the principal investigator on numerous national and local therapeutic trials and is also the principal investigator for the SPORE grant in lung cancer that is designed to conduct translational research in lung cancer.
Awardees were chosen by an advisory board of 29 oncology educators, clinicians and researchers. In evaluating criteria for selection to the inaugural class of Giants, the board considered individuals who have made a significant contribution to patient care, clinical trials or translational research.